Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 110

1.

Risk of Conversion to Dementia in a Mild Behavioral Impairment Group Compared to a Psychiatric Group and to a Mild Cognitive Impairment Group.

Taragano FE, Allegri RF, Heisecke SL, Martelli MI, Feldman ML, Sánchez V, García VA, Tufro G, Castro DM, Leguizamón PP, Guelar V, Ruotolo E, Zegarra C, Dillon C.

J Alzheimers Dis. 2018;62(1):227-238. doi: 10.3233/JAD-170632.

PMID:
29439333
2.

Serum cortisol levels and neuropsychological impairments in patients diagnosed with Fibromyalgia.

Barceló-Martinez E, Gelves-Ospina M, Navarro Lechuga E, Allegri RF, Orozco-Acosta E, Benítez-Agudelo JC, León-Jacobus A, Román NF.

Actas Esp Psiquiatr. 2018 Jan;46(1):1-11. Epub 2018 Jan 1.

3.

Utility of the Spanish version of the Everyday Cognition scale in the diagnosis of mild cognitive impairment and mild dementia in an older cohort from the Argentina-ADNI.

Russo MJ, Cohen G, Chrem Mendez P, Campos J, Martín ME, Clarens MF, Tapajoz F, Harris P, Sevlever G, Allegri RF.

Aging Clin Exp Res. 2018 Jan 29. doi: 10.1007/s40520-018-0899-8. [Epub ahead of print]

PMID:
29380265
4.

Dementia in Latin America: Assessing the present and envisioning the future.

Parra MA, Baez S, Allegri R, Nitrini R, Lopera F, Slachevsky A, Custodio N, Lira D, Piguet O, Kumfor F, Huepe D, Cogram P, Bak T, Manes F, Ibanez A.

Neurology. 2018 Jan 30;90(5):222-231. doi: 10.1212/WNL.0000000000004897. Epub 2018 Jan 5. Review.

5.

High-technology augmentative communication for adults with post-stroke aphasia: a systematic review.

Russo MJ, Prodan V, Meda NN, Carcavallo L, Muracioli A, Sabe L, Bonamico L, Allegri RF, Olmos L.

Expert Rev Med Devices. 2017 May;14(5):355-370. doi: 10.1080/17434440.2017.1324291. Epub 2017 May 9. Review.

PMID:
28446056
6.

The role of GABAA in the expression of updated information through the reconsolidation process in humans.

Fernández RS, Moyano MD, Radloff M, Campos J, Carbó-Tano M, Allegri RF, Pedreira ME, Forcato C.

Neurobiol Learn Mem. 2017 Jul;142(Pt A):146-153. doi: 10.1016/j.nlm.2017.03.014. Epub 2017 Mar 24.

PMID:
28347877
7.

Adding Recognition Discriminability Index to the Delayed Recall Is Useful to Predict Conversion from Mild Cognitive Impairment to Alzheimer's Disease in the Alzheimer's Disease Neuroimaging Initiative.

Russo MJ, Campos J, Vázquez S, Sevlever G, Allegri RF; Alzheimer's Disease Neuroimaging Initiative.

Front Aging Neurosci. 2017 Mar 10;9:46. doi: 10.3389/fnagi.2017.00046. eCollection 2017.

8.

[History of the Department of Neurology at the University of Buenos Aires (1887-2007)].

Allegri RF, Bartoloni L, Sica RE.

Vertex. 2016 Jul;XXVII(128):306-318. Spanish.

PMID:
28282088
9.

Intrafamilial variable phenotype including corticobasal syndrome in a family with p.P301L mutation in the MAPT gene: first report in South America.

Gatto EM, Allegri RF, Da Prat G, Chrem Mendez P, Hanna DS, Dorschner MO, Surace EI, Zabetian CP, Mata IF.

Neurobiol Aging. 2017 May;53:195.e11-195.e17. doi: 10.1016/j.neurobiolaging.2017.02.002. Epub 2017 Feb 10.

PMID:
28268100
10.

eNeurologicalSci - Special Issue on Neurological Disorders in South America.

Caramelli P, Conforto AB, Verdugo RJ, Allegri R.

eNeurologicalSci. 2016 Dec 15;5:41. doi: 10.1016/j.ensci.2016.12.001. eCollection 2016 Dec. No abstract available.

11.

Usefulness of Discriminability and Response Bias Indices for the Evaluation of Recognition Memory in Mild Cognitive Impairment and Alzheimer Disease.

Russo MJ, Cohen G, Campos J, Martin ME, Clarens MF, Sabe L, Barcelo E, Allegri RF.

Dement Geriatr Cogn Disord. 2017;43(1-2):1-14. doi: 10.1159/000452255. Epub 2016 Nov 26.

PMID:
27889770
12.

Neurological manifestations of autosomal dominant familial Alzheimer's disease: a comparison of the published literature with the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS).

Tang M, Ryman DC, McDade E, Jasielec MS, Buckles VD, Cairns NJ, Fagan AM, Goate A, Marcus DS, Xiong C, Allegri RF, Chhatwal JP, Danek A, Farlow MR, Fox NC, Ghetti B, Graff-Radford NR, Laske C, Martins RN, Masters CL, Mayeux RP, Ringman JM, Rossor MN, Salloway SP, Schofield PR, Morris JC, Bateman RJ; Dominantly Inherited Alzheimer Network (DIAN).

Lancet Neurol. 2016 Dec;15(13):1317-1325. doi: 10.1016/S1474-4422(16)30229-0. Epub 2016 Oct 21. Review.

13.

Predicting episodic memory performance using different biomarkers: results from Argentina-Alzheimer's Disease Neuroimaging Initiative.

Russo MJ, Cohen G, Chrem Mendez P, Campos J, Nahas FE, Surace EI, Vazquez S, Gustafson D, Guinjoan S, Allegri RF, Sevlever G.

Neuropsychiatr Dis Treat. 2016 Sep 13;12:2199-2206. eCollection 2016.

14.

Alzheimer's Disease Biomarker Profile in Cerebrospinal Fluid of Individuals with Immune-Mediated Encephalitis.

Fernandez Suarez M, Surace EI, Riudavets M, Nogues M, Vazquez S, Sevlever G, Allegri RF.

J Am Geriatr Soc. 2016 Sep;64(9):e29-31. doi: 10.1111/jgs.14291. Epub 2016 Aug 22. No abstract available.

PMID:
27550068
15.

BDNF Val66Met moderates memory impairment, hippocampal function and tau in preclinical autosomal dominant Alzheimer's disease.

Lim YY, Hassenstab J, Cruchaga C, Goate A, Fagan AM, Benzinger TL, Maruff P, Snyder PJ, Masters CL, Allegri R, Chhatwal J, Farlow MR, Graff-Radford NR, Laske C, Levin J, McDade E, Ringman JM, Rossor M, Salloway S, Schofield PR, Holtzman DM, Morris JC, Bateman RJ; Dominantly Inherited Alzheimer Network.

Brain. 2016 Oct;139(Pt 10):2766-2777. Epub 2016 Aug 12.

PMID:
27521573
16.

Validation of the Argentine version of the Memory Binding Test (MBT) for Early Detection of Mild Cognitive Impairment.

Roman F, Iturry M, Rojas G, Barceló E, Buschke H, Allegri RF.

Dement Neuropsychol. 2016 Jul-Sep;10(3):217-226. doi: 10.1590/S1980-5764-2016DN1003008.

17.

C9ORF72 G4C2-repeat expansion and frontotemporal dementia first reported case in Argentina.

Fernández Suarez M, Surace E, Harris P, Tapajoz F, Sevlever G, Allegri R, Russo GN.

Neurocase. 2016 Jun;22(3):281-4. doi: 10.1080/13554794.2016.1186700. Epub 2016 Jun 21.

PMID:
27327087
18.

Analysis of C9orf72 in patients with frontotemporal dementia and amyotrophic lateral sclerosis from Argentina.

Itzcovich T, Xi Z, Martinetto H, Chrem-Méndez P, Russo MJ, de Ambrosi B, Uchitel OD, Nogués M, Silva E, Rojas G, Bagnatti P, Amengual A, Campos J, Rogaeva E, St George-Hyslop P, Allegri R, Sevlever G, Surace EI.

Neurobiol Aging. 2016 Apr;40:192.e13-5. doi: 10.1016/j.neurobiolaging.2016.02.001. Epub 2016 Feb 6.

PMID:
26925510
19.

Obesity, metabolic profile, and inhibition failure: Young women under scrutiny.

Catoira NP, Tapajóz F, Allegri RF, Lajfer J, Rodríguez Cámara MJ, Iturry ML, Castaño GO.

Physiol Behav. 2016 Apr 1;157:87-93. doi: 10.1016/j.physbeh.2016.01.040. Epub 2016 Jan 28.

PMID:
26828037
20.

Positive modulation of a neutral declarative memory by a threatening social event.

Fernández RS, Bavassi L, Campos J, Allegri RF, Molina VA, Forcato C, Pedreira ME.

Neurobiol Learn Mem. 2015 Dec;126:56-66. doi: 10.1016/j.nlm.2015.10.011. Epub 2015 Nov 7.

PMID:
26555632
21.

Cognitive reserve and Aβ1-42 in mild cognitive impairment (Argentina-Alzheimer's Disease Neuroimaging Initiative).

Harris P, Fernandez Suarez M, Surace EI, Chrem Méndez P, Martín ME, Clarens MF, Tapajóz F, Russo MJ, Campos J, Guinjoan SM, Sevlever G, Allegri RF.

Neuropsychiatr Dis Treat. 2015 Oct 7;11:2599-604. doi: 10.2147/NDT.S84292. eCollection 2015.

22.

Emotional reactivity to social stimuli in patients with eating disorders.

Tapajóz P de Sampaio F, Soneira S, Aulicino A, Harris P, Allegri RF.

Psychiatry Res. 2015 Oct 30;229(3):887-94. doi: 10.1016/j.psychres.2015.07.049. Epub 2015 Jul 17.

PMID:
26257086
23.

[Update on the diagnosis and management of vascular cognitive impairment].

Demey I, Somale V, Allegri RF.

Vertex. 2014 Nov-Dec;25(118):437-46. Spanish.

PMID:
26098823
24.

[Non-pharmacological intervention in patients with mild Alzheimer's disease].

López N, Veliz A, Soto M, Allegri R.

Rev Esp Geriatr Gerontol. 2015 May-Jun;50(3):150-1. doi: 10.1016/j.regg.2014.11.005. Epub 2015 Jan 15. Spanish. No abstract available.

PMID:
25600121
25.

[Theory of Mind in eating disorders: endophenotype of the disease?].

Tapajóz F, Catoira N, Allegri RF.

Vertex. 2014 Jul-Aug;25(116):253-61. Review. Spanish.

PMID:
25546639
26.

Cognitive impairment and risk factor prevalence in a population over 60 in Argentina.

Arizaga RL, Gogorza RE, Allegri RF, Baumann PD, Morales MC, Harris P, Pallo V, Cegarra MM.

Dement Neuropsychol. 2014 Oct-Dec;8(4):364-370. doi: 10.1590/S1980-57642014DN84000010.

27.

A population-based study of cognitive impairment in socially vulnerable adults in Argentina. The Matanza Riachuelo study preliminary results.

Bartoloni L, Blatt G, Insua I, Furman M, González MA, Hermann B, Kesselman M, Massautis A, Reinado A, Senas P, Yavitz C, Lejarraga H, Nunes F, Arizaga RL, Allegri RF.

Dement Neuropsychol. 2014 Oct-Dec;8(4):339-344. doi: 10.1590/S1980-57642014DN84000006.

28.

Utility of the Spanish version of the FTLD-modified CDR in the diagnosis and staging in frontotemporal lobar degeneration.

Russo G, Russo MJ, Buyatti D, Chrem P, Bagnati P, Fernández Suarez M, Campos J, Cohen G, Amengual A, Allegri RF, Knopman DS.

J Neurol Sci. 2014 Sep 15;344(1-2):63-8. doi: 10.1016/j.jns.2014.06.024. Epub 2014 Jun 20.

PMID:
25015844
29.

Diagnostic accuracy of the Phototest for cognitive impairment and dementia in Argentina.

Russo MJ, Iturry M, Sraka MA, Bartoloni L, Carnero Pardo C, Allegri RF.

Clin Neuropsychol. 2014;28(5):826-40. doi: 10.1080/13854046.2014.928748. Epub 2014 Jun 27.

PMID:
24970674
30.

Creation of the Argentina-Alzheimer's Disease Neuroimaging Initiative.

Russo MJ, Gustafson D, Vázquez S, Surace E, Guinjoan S, Allegri RF, Sevlever G; Argentina-Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2014 Feb;10(1 Suppl):S84-7. Review.

PMID:
24864324
31.

Geriatric depression and its relation with cognitive impairment and dementia.

Dillon C, Tartaglini MF, Stefani D, Salgado P, Taragano FE, Allegri RF.

Arch Gerontol Geriatr. 2014 Sep-Oct;59(2):450-6. doi: 10.1016/j.archger.2014.04.006. Epub 2014 May 9.

PMID:
24855979
32.

A systematic review and meta-analysis of the diagnostic accuracy of the Phototest for cognitive impairment and dementia.

Carnero-Pardo C, Lopez-Alcalde S, Allegri RF, Russo MJ.

Dement Neuropsychol. 2014 Apr-Jun;8(2):141-147. doi: 10.1590/S1980-57642014DN82000009.

33.

Mild cognitive impairment: risk of dementia according to subtypes.

Serrano CM, Dillon C, Leis A, Taragano FE, Allegri RF.

Actas Esp Psiquiatr. 2013 Nov-Dec;41(6):330-9. Epub 2013 Nov 1.

34.

MM1+2C sporadic Creutzfeldt-Jakob disease presenting as rapidly progressive nonfluent aphasia.

Allegri RF, Bartoloni L, Iturry M, Romero C, Begué C, Sevlever G, Taratuto AL.

J Alzheimers Dis. 2014;39(1):13-7. doi: 10.3233/JAD-130350.

PMID:
24121954
35.

Theory of mind and central coherence in eating disorders: two sides of the same coin?

Tapajóz P de Sampaio F, Soneira S, Aulicino A, Martese G, Iturry M, Allegri RF.

Psychiatry Res. 2013 Dec 30;210(3):1116-22. doi: 10.1016/j.psychres.2013.08.051. Epub 2013 Sep 21.

PMID:
24064463
36.

Theory of mind in eating disorders and their relationship to clinical profile.

Tapajóz Pereira de Sampaio F, Soneira S, Aulicino A, Allegri RF.

Eur Eat Disord Rev. 2013 Nov;21(6):479-87. doi: 10.1002/erv.2247. Epub 2013 Jul 26.

PMID:
23893460
37.

Latin American experience with Alzheimer's disease cerebrospinal fluid biomarkers.

Surace E, Cohen G, Martinetto H, ChremMendez P, Martín E, Smyth E, Russo G, Amengual A, Allegri R, Leiguarda R, Sevlever G, Campos J.

J Am Geriatr Soc. 2013 Jul;61(7):1229-31. doi: 10.1111/jgs.12352. No abstract available.

PMID:
23855858
38.

The safety, tolerability, and efficacy of once-daily memantine (28 mg): a multinational, randomized, double-blind, placebo-controlled trial in patients with moderate-to-severe Alzheimer's disease taking cholinesterase inhibitors.

Grossberg GT, Manes F, Allegri RF, Gutiérrez-Robledo LM, Gloger S, Xie L, Jia XD, Pejović V, Miller ML, Perhach JL, Graham SM.

CNS Drugs. 2013 Jun;27(6):469-78. doi: 10.1007/s40263-013-0077-7.

39.

Background of the Sociedad Neurologica Argentina: current state and concerns about neurologic education.

Correale J, Allegri RF, Pelli-Noble RF.

Neurology. 2013 May 21;80(21):1978-80. doi: 10.1212/WNL.0b013e318293e17c. No abstract available.

PMID:
23690297
40.

The first steps of clinical neurology in South America.

Allegri RF, Bartoloni L.

Neurology. 2013 Apr 2;80(14):1338-40. doi: 10.1212/WNL.0b013e31828ab2b8. No abstract available.

PMID:
23547266
41.

Familial dementia with frontotemporal features associated with M146V presenilin-1 mutation.

Riudavets MA, Bartoloni L, Troncoso JC, Pletnikova O, St George-Hyslop P, Schultz M, Sevlever G, Allegri RF.

Brain Pathol. 2013 Sep;23(5):595-600. doi: 10.1111/bpa.12051. Epub 2013 Apr 25.

42.

Efficacy of a cognitive intervention program in patients with mild cognitive impairment.

Rojas GJ, Villar V, Iturry M, Harris P, Serrano CM, Herrera JA, Allegri RF.

Int Psychogeriatr. 2013 May;25(5):825-31. doi: 10.1017/S1041610213000045. Epub 2013 Feb 18.

PMID:
23414646
43.

[Review of recommendations and new diagnosis criteria for mild cognitive impairment due to Alzheimer's disease].

Allegri RF, Russo MJ, Kremer J, Taragano FE, Brusco I, Ollari JA, Serrano CM, Sarasola D, Demey I, Arizaga RL, Bagnati P.

Vertex. 2012 Jan-Feb;23(101):5-15. Spanish.

PMID:
22880190
44.

News in aging and dementia at the 13th Pan American Congress of Neurology.

Allegri RF, Russo MJ.

Expert Rev Neurother. 2012 Jul;12(7):777-9. doi: 10.1586/ern.12.57.

PMID:
22853785
45.

Cerebrolysin improves symptoms and delays progression in patients with Alzheimer's disease and vascular dementia.

Allegri RF, Guekht A.

Drugs Today (Barc). 2012 Apr;48 Suppl A:25-41. doi: 10.1358/dot.2012.48(Suppl.A).1739721. Review.

PMID:
22514793
46.

Relevance of the serial position effect in the differential diagnosis of mild cognitive impairment, Alzheimer-type dementia, and normal ageing.

Martín ME, Sasson Y, Crivelli L, Roldán Gerschovich E, Campos JA, Calcagno ML, Leiguarda R, Sabe L, Allegri RF.

Neurologia. 2013 May;28(4):219-25. doi: 10.1016/j.nrl.2012.04.013. Epub 2012 Jun 12. English, Spanish.

47.

Insurance status and demographic and clinical factors associated with pharmacologic treatment of depression: associations in a cohort in Buenos Aires.

Machnicki G, Dillon C, Allegri RF.

Value Health. 2011 Jul-Aug;14(5 Suppl 1):S13-5. doi: 10.1016/j.jval.2011.05.014.

48.

[Assessment of attention deficit hyperactivity: SNAP-IV scale adapted to Argentina].

Grañana N, Richaudeau A, Gorriti CR, O'Flaherty M, Scotti ME, Sixto L, Allegri R, Fejerman N.

Rev Panam Salud Publica. 2011 May;29(5):344-9. Spanish.

49.

Clinical manifestations of geriatric depression in a memory clinic: toward a proposed subtyping of geriatric depression.

Dillon C, Machnicki G, Serrano CM, Rojas G, Vazquez G, Allegri RF.

J Affect Disord. 2011 Nov;134(1-3):177-87. doi: 10.1016/j.jad.2011.05.036. Epub 2011 Jun 14.

PMID:
21676468
50.

Supplemental Content

Loading ...
Support Center